Correlation Between Nuvation Bio and Citius Oncology,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nuvation Bio and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvation Bio and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvation Bio and Citius Oncology,, you can compare the effects of market volatilities on Nuvation Bio and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvation Bio with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvation Bio and Citius Oncology,.

Diversification Opportunities for Nuvation Bio and Citius Oncology,

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Nuvation and Citius is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Nuvation Bio and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Nuvation Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvation Bio are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Nuvation Bio i.e., Nuvation Bio and Citius Oncology, go up and down completely randomly.

Pair Corralation between Nuvation Bio and Citius Oncology,

Given the investment horizon of 90 days Nuvation Bio is expected to generate 0.38 times more return on investment than Citius Oncology,. However, Nuvation Bio is 2.65 times less risky than Citius Oncology,. It trades about 0.05 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.15 per unit of risk. If you would invest  178.00  in Nuvation Bio on September 12, 2024 and sell it today you would earn a total of  93.00  from holding Nuvation Bio or generate 52.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy22.79%
ValuesDaily Returns

Nuvation Bio  vs.  Citius Oncology,

 Performance 
       Timeline  
Nuvation Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nuvation Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Nuvation Bio is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Citius Oncology, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Citius Oncology, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with conflicting performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Nuvation Bio and Citius Oncology, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nuvation Bio and Citius Oncology,

The main advantage of trading using opposite Nuvation Bio and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvation Bio position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.
The idea behind Nuvation Bio and Citius Oncology, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency